QIAGEN SINGAPORE PTE. LTD.

Verogen is the world's first sequencing company solely dedicated to forensic science, providing cutting-edge solutions and expert services to support labs in their mission to unlock the true potential of forensic genomics. Our commitment is to advance next-generation sequencing technologies to ensure efficient and effective human identification, ultimately contributing to justice, security, and public wellness.

QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.

QIAGEN Manila is a biotechnology company which provides services related to Supply Chain Management, Customer Care, Finance & Accounting, Technical Services and other sales support activities to QIAGEN's global operations. We complement QIAGEN’s existing Shared Service Center in Wroclaw, Poland. Supporting QIAGEN businesses specifically in the United States and the APAC region, QIAGEN Manila is expected to play an important role in the global provision of services to the company and its clients. The site is home to over 300++ diverse professionals spanning support functions from Technical Service, Customer Care, Finance, HR, Sales Support, and other fields. About QIAGEN QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of December 31, 2017, QIAGEN employed approximately 4,700 people in over 35 locations worldwide. Further information can be found at